The University of Queensland

IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling

Wilkinson, Andrew N., Chang, Karshing, Kuns, Rachel D., Henden, Andrea S., Minnie, Simone A., Ensbey, Kathleen S., Clouston, Andrew D., Zhang, Ping, Koyama, Motoko, Hidalgo, Juan, Rose-John, Stefan, Varelias, Antiopi, Vuckovic, Slavica, Gartlan, Kate H. and Hill, Geoffrey R. (2019) IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling. Blood, . doi:10.1182/blood.2019000396

Mass Cytometry Discovers Two Discrete Subsets of CD39(-)Treg Which Discriminate MGUS From Multiple Myeloma

Marsh-Wakefield, Felix, Kruzins, Annabel, McGuire, Helen M., Yang, Shihong, Bryant, Christian, de St Groth, Barbara Fazekas, Nassif, Najah, Byrne, Scott N., Gibson, John, Brown, Christina, Larsen, Stephen, McCulloch, Derek, Boyle, Richard, Clark, Georgina, Joshua, Douglas, Ho, Phoebe Joy and Vuckovic, Slavica (2019) Mass Cytometry Discovers Two Discrete Subsets of CD39(-)Treg Which Discriminate MGUS From Multiple Myeloma. Frontiers in Immunology, 10 AUG: 1596. doi:10.3389/fimmu.2019.01596

Myeloma escape after stem cell transplantation is a consequence of t-cell exhaustion and is prevented by tigit blockade

Minnie, Simone A., Kuns, Rachel D., Gartlan, Kate H., Zhang, Ping, Wilkinson, Andrew N., Samson, Luke, Guillerey, Camille, Engwerda, Christian, MacDonald, Kelli P. A., Smyth, Mark J., Markey, Kate A., Vuckovic, Slavica and Hill, Geoffrey R. (2018) Myeloma escape after stem cell transplantation is a consequence of t-cell exhaustion and is prevented by tigit blockade. Blood, 132 16: 1675-1688. doi:10.1182/blood-2018-01-825240

Granulocytes are unresponsive to IL-6 due to an absence of gp130

Wilkinson, Andrew N., Gartlan, Kate H., Kelly, Greg, Samson, Luke D., Olver, Stuart D., Avery, Judy, Zomerdijk, Nienke, Tey, Siok-Keen, Lee, Jason S., Vuckovic, Slavica and Hill, Geoffrey R. (2018) Granulocytes are unresponsive to IL-6 due to an absence of gp130. Journal of Immunology, 200 9: 3547-3555. doi:10.4049/jimmunol.1701191

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment

Nakamura, Kyohei, Kassem, Sahar, Cleynen, Alice, Chrétien, Marie-Lorraine, Guillerey, Camille, Putz, Eva Maria, Bald, Tobias, Förster, Irmgard, Vuckovic, Slavica, Hill, Geoffrey R, Masters, Seth L, Chesi, Marta, Bergsagel, P Leif, Avet-Loiseau, Hervé, Martinet, Ludovic and Smyth, Mark J. (2018) Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment. Cancer Cell, 33 4: 634-648. doi:10.1016/j.ccell.2018.02.007

Oncogenic JAK2causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Prestipino, Alessandro, Emhardt, Alica J., Aumann, Konrad, O'Sullivan, David, Gorantla, Sivahari P., Duquesne, Sandra, Melchinger, Wolfgang, Braun, Lukas, Vuckovic, Slavica, Boerries, Melanie, Busch, Hauke, Halbach, Sebastian, Pennisi, Sandra, Poggio, Teresa, Apostolova, Petya, Veratti, Pia, Hettich, Michael, Niedermann, Gabriele, Bartholomä, Mark, Shoumariyeh, Khalid, Jutzi, Jonas S., Wehrle, Julius, Dierks, Christine, Becker, Heiko, Schmitt-Graeff, Annette, Follo, Marie, Pfeifer, Dietmar, Rohr, Jan, Fuchs, Sebastian, Ehl, Stephan, Hartl, Frederike A., Minguet, Susana, Miething, Cornelius, Heidel, Florian H., Kröger, Nicolaus, Triviai, Ioanna, Brummer, Tilman, Finke, Jürgen, Illert, Anna L., Ruggiero, Eliana, Bonini, Chiara, Duyster, Justus, Pahl, Heike L., Lane, Steven W., Hill, Geoffrey R., Blazar, Bruce R., von Bubnoff, Nikolas, Pearce, Erika L. and Zeiser, Robert (2018) Oncogenic JAK2causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Science Translational Medicine, 10 429: eaam7729. doi:10.1126/scitranslmed.aam7729

The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells

Vuckovic, Slavica, Vandyke, Kate, Rickards, David A., Mccauley Winter, Padraig, Brown, Simon H. J., Mitchell, Todd W., Liu, Jun, Lu, Jun, Askenase, Philip W., Yuriev, Elizabeth, Capuano, Ben, Ramsland, Paul A., Hill, Geoffrey R., Zannettino, Andrew C. W. and Hutchinson, Andrew T. (2017) The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells. British Journal of Haematology, 177 3: 423-440. doi:10.1111/bjh.14561

Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation

Raninga, Prahlad V., Di Trapani, Giovanna, Vuckovic, Slavica and Tonissen, Kathryn F. (2016) Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation. Apoptosis, 21 12: 1422-1437. doi:10.1007/s10495-016-1303-9

Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma

Raninga, Prahlad V., Di Trapani, Giovanna, Vuckovic, Slavica and Tonissen, Kathryn F. (2016) Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma. Redox Biology, 8 175-185. doi:10.1016/j.redox.2016.01.007

Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD

Tey, S-K, Vuckovic, S., Varelias, A., Martins, J. P., Olver, S., Samson, L., Sturgeon, E., Leach, J., Avery, J., Nakagaki, M., Butler, J. P., Curley, C., Morton, A. J., Durrant, S. T., Kennedy, G. A. and Hill, G. R. (2016) Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD. Bone Marrow Transplantation, 51 8: 1153-1155. doi:10.1038/bmt.2016.83

Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies

Guillerey, Camille, Nakamura, Kyohei, Vuckovic, Slavica, Hill, Geoffrey R. and Smyth, Mark J. (2016) Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies. Cellular and Molecular Life Sciences, 73 8: 1569-1589. doi:10.1007/s00018-016-2135-z

TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition

Raninga, Prahlad V., Di Trapani, Giovanna, Vuckovic, Slavica and Tonissen, Kathryn F. (2016) TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition. Cell Cycle, 15 4: 559-572. doi:10.1080/15384101.2015.1136038

Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease

Koyama, Motoko, Cheong, Melody, Markey, Kate A., Gartlan, Kate H., Kuns, Rachel D., Locke, Kelly R., Lineburg, Katie E., Teal, Bianca E., Leveque-El Mouttie, Lucie, Bunting, Mark D., Vuckovic, Slavica, Zhang, Ping, Teng, Michele W. L., Varelias, Antiopi, Tey, Siok-Keen, Wockner, Leesa F., Engwerda, Christian R., Smyth, Mark J., Belz, Gabrielle T., McColl, Shaun R., MacDonald, Kelli P. A. and Hill, Geoffrey R. (2015) Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease. Journal of Experimental Medicine, 212 8: 1303-1321. doi:10.1084/jem.20150329

Erratum: Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Guillerey, Camille, de Andrade, Lucas Ferrari, Vuckovic, Slavica, Miles, Kim, Ngiow, Shin Foong, Yong, Michelle C. R., Teng, Michele W. L., Colonna, Marco, Ritchie, David S., Chesi, Marta, Bergsagel, P. Leif, Hill, Geoffrey R., Smyth, Mark J. and Martinet, Ludovic (2015) Erratum: Immunosurveillance and therapy of multiple myeloma are CD226 dependent. Journal of Clinical Investigation, 125 7: 2904-2904. doi:10.1172/JCI82646

Reactivated CD4+Tm cells of T1D patients and siblings display an exaggerated effector phenotype with heightened sensitivity to activation-induced cell death

Bian, Michael Lei, Haigh, Oscar, Munster, David, Harris, Mark, Cotterill, Andrew, Miles, John J. and Vuckovic, Slavica (2015) Reactivated CD4+Tm cells of T1D patients and siblings display an exaggerated effector phenotype with heightened sensitivity to activation-induced cell death. Diabetes, 64 6: 2161-2171. doi:10.2337/db14-1151

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Guillerey, Camille, de Andrade, Lucas Ferrari, Vuckovic, Slavica, Miles, Kim, Ngiow, Shin Foong, Yong, Michelle C. R., Teng, Michele W. L., Colonna, Marco, Ritchie, David S., Chesi, Martha, Bergsagel, P. Leif, Hill, Geoffrey R., Smyth, Mark J. and Martinet, Ludovic (2015) Immunosurveillance and therapy of multiple myeloma are CD226 dependent. Journal of Clinical Investigation, 125 5: 2077-2089. doi:10.1172/JCI77181

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Kennedy, Glen A., Varelias, Antiopi, Vuckovic, Slavica, Le Texier, Laetitia, Gartlan, Kate H., Zhang, Ping, Thomas, Gethin, Anderson, Lisa, Boyle, Glen, Cloonan, Nicole, Leach, Justine, Sturgeon, Elise, Avery, Judy, Olver, Stuart D., Lor, Mary, Misra, Ashish K., Hutchins, Cheryl, Morton, A. James, Durrant, Simon T. S., Subramoniapillai, Elango, Butler, Jason P., Curley, Cameron I., MacDonald, Kelli P. A., Tey, Siok-Keen and Hill, Geoffrey R. (2014) Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. The Lancet Oncology, 15 13: 1451-1459. doi:10.1016/S1470-2045(14)71017-4

FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo

Ding, Yitian, Wilkinson, Andrew, Idris, Adi, Fancke, Ben, O’Keeffe, Meredith, Khalil, Dalia, Ju, Xinsheng, Lahoud, Mireille H., Caminschi, Irina, Shortman, Ken, Rodwell, Robyn, Vuckovic, Slavica and Radford, Kristen J. (2014) FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo. Journal of Immunology, . doi:10.4049/​jimmunol.1302391

Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib

Sanchez, W. Y., McGee, S. L., Connor, T., Mottram, B., Wilkinson, A., Whitehead, J. P., Vuckovic, S. and Catley, L. (2013) Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib. British Journal of Cancer, 108 8: 1624-1633. doi:10.1038/bjc.2013.120

Myeloma-Induced Alloreactive T Cells Arising in Myeloma-Infiltrated Bones Include Double-Positive CD8(+)CD4(+) T Cells: Evidence from Myeloma-Bearing Mouse Model

Freeman, Lisa M., Lam, Alfred, Petcu, Eugene, Smith, Robert, Salajegheh, Ali, Diamond, Peter, Zannettino, Andrew, Evdokiou, Andreas, Luff, John, Wong, Pooi-Fong, Khalil, Dalia, Waterhouse, Nigel, Vari, Frank, Rice, Alison M., Catley, Laurence, Hart, Derek N. J. and Vuckovic, Slavica (2011) Myeloma-Induced Alloreactive T Cells Arising in Myeloma-Infiltrated Bones Include Double-Positive CD8(+)CD4(+) T Cells: Evidence from Myeloma-Bearing Mouse Model. Journal of Immunology, 187 8: 3987-3996. doi:10.4049/jimmunol.1101202

Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells

Dean, Melinda M., Flower, Robert L., Eisen, Damon P., Minchinton, Robyn M., Hart, Derek N. J. and Vuckovic, Slavica (2011) Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells. Immunology, 132 2: 295-305. doi:10.1111/j.1365-2567.2010.03365.x

Type 1 Diabetic Children and Siblings Share a Decrease in Dendritic Cell and Monocyte Numbers but are Differentiated by Expansion of CD4+T Cells Expressing IL-17

Wilkinson, Andrew, Bian, Lei, Khalil, Dalia, Gibbons, Kristen, Wong, Pooi-Fong, Hart, Derek N.J., Harris, Mark, Cotterill, Andrew and Vuckovic, Slavica (2011) Type 1 Diabetic Children and Siblings Share a Decrease in Dendritic Cell and Monocyte Numbers but are Differentiated by Expansion of CD4+T Cells Expressing IL-17. Journal of Clinical and Cellular Immunology, S2 001: 1-9.

Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.

Vuckovic, S., Wahid, F.S.A., Rice, A. M., Kato, M., Khalil, D., Rodwell, R. and Hart, D. N. J. (2008) Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.. Experimental Hematology, 36 11: 1502-1512. doi:10.1016/j.exphem.2008.06.011

Decreased blood dendritic cell counts in type 1 diabetic children

Vuckovic, Slavica, Withers, Geoff, Harris, Mark, Khalil, Dalia, Gardiner, Damien, Flesch, Inge, Tepes, Sonia, Greer, Ristan, Cowley, David, Cotterill, Andrew and Hart, Derek N.J. (2007) Decreased blood dendritic cell counts in type 1 diabetic children. Clinical Immunology, 123 3: 281-288. doi:10.1016/j.clim.2007.03.002

Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4(+) T memory cells with mixed helper/regulatory function

McKinlay, Adam, Radford, Kristen, Kato, Masato, Field, Ken, Gardiner, Damien, Khalil, Dalia, Burnell, Fiona, Hart, Derek and Vuckovic, Slavica (2007) Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4(+) T memory cells with mixed helper/regulatory function. Immunology, 120 3: 392-403. doi:10.1111/j.1365-2567.2006.02515.x

Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease

Lau, J., Sartor, M., Bradstock, K. F., Vuckovic, S., Munster, D. J. and Hart, D. N. J. (2007) Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease. Transplantation, 83 7: 839-846. doi:10.1097/01.tp.0000258731.38149.61

Cord blood CD34+ cells cultured with FLT3L, stem cell factor, Interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cells

Fadilah, S. A. W., Vuckovic, S., Khalil, D. and Hart, D.N.J. (2007) Cord blood CD34+ cells cultured with FLT3L, stem cell factor, Interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cells. Stem Cells and Development, 16 5: 849-855. doi:10.1089/scd.2007.0003

Expression of human DEC-205 (CD205) multilectin receptor on leukocytes

Kato, Masato, McDonald, Kylie J ., Khan, Seema, Ross, Ian L., Vuckovic, Slavica, Chen, Ke, Munster, David, MacDonald, Kelli P. A. and Hart, Derek N. J. (2006) Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. International Immunology, 18 6: 857-869. doi:10.1093/intimm/dxl022

Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay

Vuckovic, S., Gardiner, D., Field, K., Chapman, G. V., Khalil, D., Gill, D., Marlton, P., Taylor, K., Wright, S., Pinzon-Charry, A., Pyke, C. M., Rodwell, R., Hockey, R. L., Gleeson, M., Tepes, S., True, D., Cotterill, A. and Hart, D. N. J. (2004) Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. Journal of Immunological Methods, 284 1-2: 73-87. doi:10.1016/j.jim.2003.10.006

Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression

Vuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003) Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 6: 2314-2317. doi:10.1182/blood-2002-03-0973

Single step isolation of blood dendritic cells by positive immunoselection

López, Alejandro, Bioley, Gilles, Turtle, Cameron J., Pinzón-Charry, Alberto, Ho, Chris S. K., Vuckovic, Slavica, Crosbie, Georgina, Gilleece, Maria, Jackson, David C., Munster, David and Hart, Derek N. J. (2003) Single step isolation of blood dendritic cells by positive immunoselection. Journal of Immunological Methods, 274 1-2: 47-61. doi:10.1016/S0022-1759(02)00429-5

Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy

Jose Lopez, Crosbie, Georgina, Kelly, Cathryn, McGee, Ann Marie, Williams, Katrina, Vuckovic, Slavica, Schuyler, Robert, Rodwell, Robyn, Wright, Sue J., Taylor, Kerry and Hart, Derek N. J. (2002) Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy. Journal of Immunological Methods, 267 2: 199-212. doi:10.1016/S0022-1759(02)00185-0

The role of dendritic cells in the innate immune system

Clark, Georgina J., Angel, Nicola, Kato, Masato, Lopez, J. Alejandro, MacDonald, Kelli, Vuckovic, Slavica and Hart, Derek N. J. (2000) The role of dendritic cells in the innate immune system. Microbes and Infection, 2 3: 257-272. doi:10.1016/S1286-4579(00)00302-6

Circulating dendritic cells are reduced in patients with active ulcerative colitis but not in patients with active Crohn's disease.

Florin, TH, Vuckovic, S, Patel, K, Khalil, D, Webb, N and Hart, DN (2000) Circulating dendritic cells are reduced in patients with active ulcerative colitis but not in patients with active Crohn's disease.. Gastroenterology, 118 4: A343-A343.

Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells

Kato, M., Neil, T. K., Fearnley, D. B., McLellan, A. D., Vuckovic, S. and Hart, D. N. J. (2000) Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. International Immunology, 12 11: 1511-1519. doi:10.1093/intimm/12.11.1511

Dendritic cells in chronic myelomocytic leukaemia.

Vuckovic, S., Fearnley, D. B., Gunningham, S., Spearing, R. L., Patton, W. N. and Hart, D. (1999) Dendritic cells in chronic myelomocytic leukaemia.. British Journal of Haematology, 105 4: 974-985. doi:10.1046/j.1365-2141.1999.01431.x

Expression of the Re1B transcription factor correlates with the activation of human dendritic cells

Clark, G. J., Gunningham, S., Troy, A., Vuckovic, S. and Hart, D. (1999) Expression of the Re1B transcription factor correlates with the activation of human dendritic cells. Immunology, 98 2: 189-196.

Immunoregulation of Human Myeloid Dendritic Cells and Monocytes by Vascular Endothelial Growth Factor

Sanchez, Washington Yamandu, Jr., Wang, Ran, Wilkinson, Andrew, Khalil, Dalia, Hart, Derek N. J., Catley, Laurence and Vuckovic, Slavica (2011). Immunoregulation of Human Myeloid Dendritic Cells and Monocytes by Vascular Endothelial Growth Factor. In: Blood. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego Ca, (1387-1387). Dec 10-13, 2011.

Depletion of host CD122(+) cells facilitates widespread skeletal multiple myeloma engraftment in NOD/SCID recipients

Freeman, Lisa M., Petcu, Eugene, Smith, Robert, Salajegheh, Ali, Diamond, Peter, Zannettino, Andrew Christopher William, Evdokiou, Andreas, Luff, John, Khalil, Dalia, Vari, Frank, Catley, Lawrence, Hart, Derek and Vuckovic, Slavica (2008). Depletion of host CD122(+) cells facilitates widespread skeletal multiple myeloma engraftment in NOD/SCID recipients. In: Abstracts of the American Society of Hematology 50th Annual Meeting. 50th Annual Meeting of the American Society of Hematology/ASH/ASCO Joint Symposium, San Francisco Ca, (945-945). 06-09 December 2008.

Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responses

Mckinlay, A, Radford, KJ, Gardiner, D, Khalil, D, Field, K, Burnell, F, Hart, DNJ and Vuckovic, S (2005). Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responses. In: Tissue Antigens. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, (581-582). Nov 29-Dec 02, 2005.

RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy

Turtle, C. J., Radford, K. J., Allan, C. P., Kassianos, A., Kato, M., Vuckovic, S., MacDonald, K.J., Lopez, Jose A., Jackson, D. C., Wright, S., Taylor, K., Marlton, P., Gill, D., Hart, D. N. J. and Korngold, R. (2004). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy. In: Biology of Blood and Marrow Transplantation. Tandem BMT 2004 Meeting, Orlando, Florida, U.S., (71-71). 13-17 February 2004. doi:10.1016/j.bbmt.2003.12.081

Dendritic cell analysis on G-CSF mobilised normals and patients

Vuckovic, S., Kim, M., Khalil, D., McGee, A. M., Williams, N. I., Brown, L., Kelly, C., Rodwell, R., Wright, S., Taylor, K., Hill, G. and Hart, D. (2000). Dendritic cell analysis on G-CSF mobilised normals and patients. In: Proceedings of the 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand. 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, Australia, (1631-1631). July 2000.

Divergent expression of CMRF44 on blood dendritic cells of UC & CD patients & upregulation of CD40 & CD86

Florin, T. H., Vuckovic, S., Khalil, D., Brown, L. and Hart, D. N. J. (2000). Divergent expression of CMRF44 on blood dendritic cells of UC & CD patients & upregulation of CD40 & CD86. In: Australian Gastroenterology Week. Australian Gastroenterology and Hepatology, Hobart, Australia, (J28-J28). October 2000.

Blood dendritic cell counts are reduced in some inflammatory bowel diseases

Florin, T. H., Vuckovic, S., Patel, K., Webb, N. A., Hamilton, I., Hill, G.R. and Hart, D.N.J. (1999). Blood dendritic cell counts are reduced in some inflammatory bowel diseases. In: Blood: Abstracts of the 41st annual meeting of the American Society of Hematology (ASH). 41st annual meeting of the American Society of Hematology (ASH), New Orleans, Louisiana, (39B-39B). December, 1999.